Details of the Drug

General Information of Drug (ID: DMVNM9G)

Drug Name

177 Lu PSMA-617 targeted radioligand therapy

Indication

Disease Entry	ICD 11	Status	REF
Prostate cancer	2C82.0	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)